Researchers report that retinol accumulating with age activates SREBP1 and its downstream fatty acid elongase ELOVL6 in natural killer cells, altering membrane lipid composition and the mechanical properties the cells rely on to engage and kill targets. The resulting loss of cytotoxic function weakens tumor surveillance, and inhibiting ELOVL6 restored NK cell-mediated tumor control in aged models.
Key Points
- Age-related retinol signaling drives SREBP1–ELOVL6 lipid remodeling in NK cells
- Altered membrane mechanics impair NK cell target engagement and killing
- ELOVL6 inhibition restored tumor control in aged models
Longevity Analysis
Immune decline with age is framed here as a physical problem as much as a transcriptional one: the stiffness and deformability of a killer cell's membrane determine whether it can form a functional synapse with a malignant target. Lipid handling, vitamin A metabolism, and surveillance capacity are shown to be a single continuous chain, which means metabolic inputs that appear nutritional sit upstream of whether abnormal cells are cleared. ELOVL6 offers a defined intervention point, but the broader implication is that preserving cytotoxic competence may depend on managing the lipid environment these cells inhabit long before function visibly fails.
Original published by Nature Aging, by Xinru Liu.